DD207150A5 - Verfahren zum ueberziehen von arzneiformen mittels eines in wasser dispergierten ueberzugsmittels - Google Patents

Verfahren zum ueberziehen von arzneiformen mittels eines in wasser dispergierten ueberzugsmittels Download PDF

Info

Publication number: DD207150A5
Authority: DD; German Democratic Republic
Prior art keywords: weight; units; salt; agent; monomer units
Prior art date: 1982-03-11

Application number

DD83248556A

Other languages

German (de)

English (en)

Inventor

Klaus Lehmann

Dieter Dreher

Hubert Rauch

Werner Siol

Original Assignee

Roehm Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1982-03-11

Filing date

1983-03-07

Publication date

1984-02-22

1983-03-07 Application filed by Roehm Gmbh filed Critical Roehm Gmbh

1984-02-22 Publication of DD207150A5 publication Critical patent/DD207150A5/de

Links

238000000034 method Methods 0.000 title claims abstract description 22
229940126601 medicinal product Drugs 0.000 title 1
239000011248 coating agent Substances 0.000 claims abstract description 41
238000000576 coating method Methods 0.000 claims abstract description 31
150000003839 salts Chemical class 0.000 claims abstract description 21
239000003795 chemical substances by application Substances 0.000 claims abstract description 16
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 16
239000002552 dosage form Substances 0.000 claims abstract description 11
239000000203 mixture Substances 0.000 claims abstract description 6
239000000178 monomer Substances 0.000 claims description 35
229920000126 latex Polymers 0.000 claims description 27
239000004816 latex Substances 0.000 claims description 26
239000002245 particle Substances 0.000 claims description 25
239000000843 powder Substances 0.000 claims description 21
239000004908 Emulsion polymer Substances 0.000 claims description 15
230000015572 biosynthetic process Effects 0.000 claims description 14
229920000642 polymer Polymers 0.000 claims description 12
CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 11
239000008199 coating composition Substances 0.000 claims description 9
SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 8
239000011230 binding agent Substances 0.000 claims description 8
238000006243 chemical reaction Methods 0.000 claims description 6
239000008187 granular material Substances 0.000 claims description 6
238000002360 preparation method Methods 0.000 claims description 6
230000002378 acidificating effect Effects 0.000 claims description 5
125000005907 alkyl ester group Chemical group 0.000 claims description 4
238000001704 evaporation Methods 0.000 claims description 4
239000000839 emulsion Substances 0.000 claims 1
239000006185 dispersion Substances 0.000 abstract description 18
229920005989 resin Polymers 0.000 abstract 2
239000011347 resin Substances 0.000 abstract 2
229920003002 synthetic resin Polymers 0.000 abstract 1
239000000057 synthetic resin Substances 0.000 abstract 1
CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 8
239000003814 drug Substances 0.000 description 8
229940079593 drug Drugs 0.000 description 7
239000002253 acid Substances 0.000 description 6
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 6
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
230000009477 glass transition Effects 0.000 description 6
239000000243 solution Substances 0.000 description 6
238000003756 stirring Methods 0.000 description 5
239000003826 tablet Substances 0.000 description 5
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 4
150000007513 acids Chemical class 0.000 description 4
210000004051 gastric juice Anatomy 0.000 description 4
239000007787 solid Substances 0.000 description 4
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
239000000654 additive Substances 0.000 description 3
239000007864 aqueous solution Substances 0.000 description 3
-1 dimethylaminoneopentyl Chemical group 0.000 description 3
150000002148 esters Chemical class 0.000 description 3
230000008020 evaporation Effects 0.000 description 3
235000011389 fruit/vegetable juice Nutrition 0.000 description 3
239000010410 layer Substances 0.000 description 3
PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 3
239000004014 plasticizer Substances 0.000 description 3
238000001694 spray drying Methods 0.000 description 3
NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
239000002671 adjuvant Substances 0.000 description 2
125000003277 amino group Chemical group 0.000 description 2
229910021529 ammonia Inorganic materials 0.000 description 2
230000000694 effects Effects 0.000 description 2
230000000968 intestinal effect Effects 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
239000003960 organic solvent Substances 0.000 description 2
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
239000000725 suspension Substances 0.000 description 2
230000008961 swelling Effects 0.000 description 2
238000003786 synthesis reaction Methods 0.000 description 2
239000002700 tablet coating Substances 0.000 description 2
238000009492 tablet coating Methods 0.000 description 2
125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
HXVJQEGYAYABRY-UHFFFAOYSA-N 1-ethenyl-4,5-dihydroimidazole Chemical compound C=CN1CCN=C1 HXVJQEGYAYABRY-UHFFFAOYSA-N 0.000 description 1
OSSNTDFYBPYIEC-UHFFFAOYSA-N 1-ethenylimidazole Chemical compound C=CN1C=CN=C1 OSSNTDFYBPYIEC-UHFFFAOYSA-N 0.000 description 1
DBNWKFDFDWDROA-UHFFFAOYSA-N 1-ethenylimidazolidine Chemical compound C=CN1CCNC1 DBNWKFDFDWDROA-UHFFFAOYSA-N 0.000 description 1
CARNAGUYRNYJLM-UHFFFAOYSA-N 2-(cyclohexylamino)ethyl prop-2-enoate Chemical compound C=CC(=O)OCCNC1CCCCC1 CARNAGUYRNYJLM-UHFFFAOYSA-N 0.000 description 1
QHVBLSNVXDSMEB-UHFFFAOYSA-N 2-(diethylamino)ethyl prop-2-enoate Chemical compound CCN(CC)CCOC(=O)C=C QHVBLSNVXDSMEB-UHFFFAOYSA-N 0.000 description 1
DPBJAVGHACCNRL-UHFFFAOYSA-N 2-(dimethylamino)ethyl prop-2-enoate Chemical compound CN(C)CCOC(=O)C=C DPBJAVGHACCNRL-UHFFFAOYSA-N 0.000 description 1
HWNIMFWVBMOWHI-UHFFFAOYSA-N 2-morpholin-4-ylethyl prop-2-enoate Chemical compound C=CC(=O)OCCN1CCOCC1 HWNIMFWVBMOWHI-UHFFFAOYSA-N 0.000 description 1
FGSBZZTYGCQZPD-UHFFFAOYSA-N 2-piperidin-1-ylethyl prop-2-enoate Chemical compound C=CC(=O)OCCN1CCCCC1 FGSBZZTYGCQZPD-UHFFFAOYSA-N 0.000 description 1
KGIGUEBEKRSTEW-UHFFFAOYSA-N 2-vinylpyridine Chemical compound C=CC1=CC=CC=N1 KGIGUEBEKRSTEW-UHFFFAOYSA-N 0.000 description 1
QGXMPHBQJFXJCI-UHFFFAOYSA-N 4-(dimethylamino)butyl prop-2-enoate Chemical compound CN(C)CCCCOC(=O)C=C QGXMPHBQJFXJCI-UHFFFAOYSA-N 0.000 description 1
HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
235000001674 Agaricus brunnescens Nutrition 0.000 description 1
NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
239000005977 Ethylene Substances 0.000 description 1
VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
150000001336 alkenes Chemical class 0.000 description 1
125000000217 alkyl group Chemical group 0.000 description 1
229910000147 aluminium phosphate Inorganic materials 0.000 description 1
150000001412 amines Chemical class 0.000 description 1
125000004103 aminoalkyl group Chemical group 0.000 description 1
235000011114 ammonium hydroxide Nutrition 0.000 description 1
125000000129 anionic group Chemical group 0.000 description 1
239000002775 capsule Substances 0.000 description 1
125000004432 carbon atom Chemical group C* 0.000 description 1
150000007942 carboxylates Chemical group 0.000 description 1
150000001735 carboxylic acids Chemical class 0.000 description 1
125000002091 cationic group Chemical group 0.000 description 1
239000011247 coating layer Substances 0.000 description 1
230000001427 coherent effect Effects 0.000 description 1
238000001816 cooling Methods 0.000 description 1
125000004985 dialkyl amino alkyl group Chemical group 0.000 description 1
238000009792 diffusion process Methods 0.000 description 1
239000007884 disintegrant Substances 0.000 description 1
239000008298 dragée Substances 0.000 description 1
238000001035 drying Methods 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
239000012634 fragment Substances 0.000 description 1
238000004108 freeze drying Methods 0.000 description 1
230000002496 gastric effect Effects 0.000 description 1
125000002768 hydroxyalkyl group Chemical group 0.000 description 1
239000011229 interlayer Substances 0.000 description 1
238000002955 isolation Methods 0.000 description 1
LVHBHZANLOWSRM-UHFFFAOYSA-N itaconic acid Chemical class OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 1
239000000463 material Substances 0.000 description 1
238000005259 measurement Methods 0.000 description 1
150000002734 metacrylic acid derivatives Chemical class 0.000 description 1
FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 1
WDQKICIMIPUDBL-UHFFFAOYSA-N n-[2-(dimethylamino)ethyl]prop-2-enamide Chemical compound CN(C)CCNC(=O)C=C WDQKICIMIPUDBL-UHFFFAOYSA-N 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
239000008188 pellet Substances 0.000 description 1
239000000049 pigment Substances 0.000 description 1
239000004033 plastic Substances 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
229940072033 potash Drugs 0.000 description 1
BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 1
235000015320 potassium carbonate Nutrition 0.000 description 1
235000011118 potassium hydroxide Nutrition 0.000 description 1
QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
238000011084 recovery Methods 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 description 1
239000001509 sodium citrate Substances 0.000 description 1
235000011121 sodium hydroxide Nutrition 0.000 description 1
239000000126 substance Substances 0.000 description 1
239000004094 surface-active agent Substances 0.000 description 1
239000000454 talc Substances 0.000 description 1
229910052623 talc Inorganic materials 0.000 description 1
239000011975 tartaric acid Substances 0.000 description 1
235000002906 tartaric acid Nutrition 0.000 description 1
230000028016 temperature homeostasis Effects 0.000 description 1
125000001302 tertiary amino group Chemical group 0.000 description 1
HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
229940038773 trisodium citrate Drugs 0.000 description 1
229920001567 vinyl ester resin Polymers 0.000 description 1
229920002554 vinyl polymer Polymers 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Medicinal Preparation (AREA)
Ink Jet (AREA)
External Artificial Organs (AREA)
Dental Preparations (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DD83248556A 1982-03-11 1983-03-07 Verfahren zum ueberziehen von arzneiformen mittels eines in wasser dispergierten ueberzugsmittels DD207150A5 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE3208791A DE3208791A1 (de)	1982-03-11	1982-03-11	Verfahren zum ueberziehen von arzneiformen mittes eines in wasser dispergierten ueberzugsmittels

Publications (1)

Publication Number	Publication Date
DD207150A5 true DD207150A5 (de)	1984-02-22

Family

ID=6157932

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DD83248556A DD207150A5 (de)	1982-03-11	1983-03-07	Verfahren zum ueberziehen von arzneiformen mittels eines in wasser dispergierten ueberzugsmittels

Country Status (8)

Country	Link
US (1)	US4520172A (fr)
EP (1)	EP0088951B1 (fr)
JP (1)	JPS58167521A (fr)
AT (1)	ATE27908T1 (fr)
DD (1)	DD207150A5 (fr)
DE (2)	DE3208791A1 (fr)
FI (1)	FI77780C (fr)
HU (1)	HU187058B (fr)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE457505B (sv) *	1984-01-10	1989-01-09	Lejus Medical Ab	Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
DE3405378A1 (de) *	1984-02-15	1985-08-22	Röhm GmbH, 6100 Darmstadt	Arzneimittelueberzug
DE3421860C2 (de) *	1984-06-13	1994-09-15	Roehm Gmbh	Verfahren zum Überziehen von Arzneiformen
DE3438291A1 (de) *	1984-10-19	1986-04-24	Röhm GmbH, 6100 Darmstadt	Verfahren zur herstellung einer waessrigen ueberzugsmitteldispersion und ihre verwendung zum ueberziehen von arzneimitteln
US4786508A (en) *	1986-05-30	1988-11-22	Warner-Lambert Company	Coated dosage forms
DE3702997A1 (de) *	1987-02-02	1988-08-11	Roehm Gmbh	Verfahren zur herstellung eines redispergierbaren kunststoffpulvers
JPS63188621A (ja) *	1987-01-30	1988-08-04	Taisho Pharmaceut Co Ltd	矯味経口製剤
DE3723668A1 (de) *	1987-07-17	1989-01-26	Roehm Gmbh	Staubarmes spruehgetrocknetes emulsionspolymerisat und verfahren zu seiner herstellung und anwendung
US5248516A (en) *	1989-12-19	1993-09-28	Fmc Corporation	Film-forming composition: method of producing same and use for coating pharmaceuticals and foods and the like
DE4133192A1 (de) *	1991-10-07	1993-04-08	Basf Ag	Verfahren zum ueberziehen von arzneiformen
JP3142919B2 (ja) *	1991-11-06	2001-03-07	旭化成株式会社	セルロース誘導体ラテックス及びその製法
US5266331A (en) *	1991-11-27	1993-11-30	Euroceltique, S.A.	Controlled release oxycodone compositions
US5958459A (en) *	1991-12-24	1999-09-28	Purdue Pharma L.P.	Opioid formulations having extended controlled released
US5681585A (en) *	1991-12-24	1997-10-28	Euro-Celtique, S.A.	Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
US5968551A (en) *	1991-12-24	1999-10-19	Purdue Pharma L.P.	Orally administrable opioid formulations having extended duration of effect
US5478577A (en) *	1993-11-23	1995-12-26	Euroceltique, S.A.	Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
US5580578A (en) *	1992-01-27	1996-12-03	Euro-Celtique, S.A.	Controlled release formulations coated with aqueous dispersions of acrylic polymers
US7070806B2 (en) *	1992-01-27	2006-07-04	Purdue Pharma Lp	Controlled release formulations coated with aqueous dispersions of acrylic polymers
US20080075781A1 (en) *	1992-11-25	2008-03-27	Purdue Pharma Lp	Controlled release oxycodone compositions
DE4318375A1 (de) *	1993-05-28	1994-12-01	Rottendorf Pharma Gmbh	Mischung zur Schaffung von Filmüberzügen für Tabletten od. dgl.
US20070275062A1 (en) *	1993-06-18	2007-11-29	Benjamin Oshlack	Controlled release oxycodone compositions
US7740881B1 (en)	1993-07-01	2010-06-22	Purdue Pharma Lp	Method of treating humans with opioid formulations having extended controlled release
IL110014A (en) *	1993-07-01	1999-11-30	Euro Celtique Sa	Solid controlled-release oral dosage forms of opioid analgesics
US5879705A (en) *	1993-07-27	1999-03-09	Euro-Celtique S.A.	Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
US6165988A (en) *	1995-02-10	2000-12-26	Christian Noe	Medicament in particulate form
DE19617716A1 (de)	1996-05-03	1997-11-06	Basf Ag	In wäßriger Lösung redispergierbare Polymerpulver
HRP970485A2 (en)	1996-09-13	1998-08-31	Joerg Rosenberg	Process for producing solid pharmaceutical forms
US6806294B2 (en)	1998-10-15	2004-10-19	Euro-Celtique S.A.	Opioid analgesic
DE19911623A1 (de) *	1999-03-16	2000-09-28	Polymar Gmbh	Verfahren zur Herstellung bei Raumtemperatur fester Konzentrate und Konzentrat für wäßrige Dispersionslacke, -farben oder Coatings sowie Verfahren zur Herstellung wäßriger Dispersionslacke, -farben oder Coatings aus dem Konzentrat
KR100889069B1 (ko)	1999-10-29	2009-03-17	유로-셀티크 소시에떼 아노뉨	서방성 하이드로코돈 제형
US10179130B2 (en)	1999-10-29	2019-01-15	Purdue Pharma L.P.	Controlled release hydrocodone formulations
US6420473B1 (en) *	2000-02-10	2002-07-16	Bpsi Holdings, Inc.	Acrylic enteric coating compositions
DE60128215T2 (de)	2000-04-20	2008-01-10	Novartis Ag	Beschichtungszusammensetzung zur geschmacksmaskierung
AU2738302A (en)	2000-10-30	2002-05-15	Euro Celtique Sa	Controlled release hydrocodone formulations
UA81224C2 (uk) *	2001-05-02	2007-12-25	Euro Celtic S A	Дозована форма оксикодону та її застосування
WO2005097197A1 (fr) *	2004-04-05	2005-10-20	Basf Aktiengesellschaft	Particules polymeres contenant des agents actifs
DE102004046102B4 (de) *	2004-09-23	2009-09-03	Mars Inc.	Indikatorgranulat
DE102005007059A1 (de)	2005-02-15	2006-08-24	Röhm GmbH & Co. KG	Teilneutralisiertes anionisches (Meth)acrylat-Copolymer
US20080075768A1 (en) *	2006-07-21	2008-03-27	Vaughn Jason M	Hydrophobic opioid abuse deterrent delivery system using opioid antagonists
DE102006035549A1 (de)	2006-07-27	2008-01-31	Evonik Röhm Gmbh	Arzneiform mit mindestens zweischichtiger Trennschicht
US20080118570A1 (en) *	2006-11-20	2008-05-22	Zhi Liu	Polymer coated drug-ion exchange resins and methods
DK2152250T3 (da)	2007-05-07	2019-12-09	Evonik Degussa Gmbh	Faste doseringsformer, der omfatter et enterisk overtræk, med accelereret lægemiddelfrigivelse
BR112012021445B8 (pt)	2010-02-25	2022-07-05	Evonik Roehm Gmbh	formulação farmacêutica ou neutracêutica, e uso de um agente promotor de biodisponibilidade
BR112013020877B1 (pt)	2011-02-28	2020-06-02	Basf Se	Processo para produzir composições de revestimento pulverulentas
US8962064B2 (en)	2011-02-28	2015-02-24	Basf Se	Production of pulverulent coating compositions for stable protective coatings for pharmaceutical dosage forms
US8865250B2 (en)	2011-02-28	2014-10-21	Basf Se	Production of pulverulent coating compositions for stable protective coatings for pharmaceutical dosage forms
BR112013021510B1 (pt)	2011-02-28	2020-09-24	Basf Se	Processo para a produção de composições de revestimento em pó, e, uso de um pó de polímero
DE102011082716A1 (de) *	2011-09-14	2013-03-14	Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.	Indikatorelement mit einer von einer in kontakt zu bringenden substanz abhängigen farbgebung
US20130236505A1 (en)	2012-03-09	2013-09-12	Basf Se	Production Of Pharmaceutical Protective Coatings With Good Resistance In A Neutral Environment
EP2636403A1 (fr)	2012-03-09	2013-09-11	Basf Se	Fabrication de revêtements de protection pharmaceutiques ayant une bonne résistance en milieu neutre
CN104893399A (zh) *	2014-03-07	2015-09-09	陶氏环球技术有限公司	含有三胺官能化的分散剂的涂料组合物
CA2936740C (fr)	2014-10-31	2017-10-10	Purdue Pharma	Methodes et compositions destinees au traitement du trouble de deficit d'attention
US10722473B2 (en)	2018-11-19	2020-07-28	Purdue Pharma L.P.	Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE785702A (fr) *	1971-07-14	1972-10-16	Roehm Gmbh	Produits de revetement de formes medicamenteuses et leur utilisation
DE2512238C2 (de) *	1975-03-20	1977-01-13	Roehm Gmbh	Bindemittel fuer arzneimittelueberzuege
US4112215A (en) *	1975-03-20	1978-09-05	Rohm Gmbh	Copolymeric resin binder powders
DE3049179A1 (de) *	1975-03-20	1982-07-29	Röhm GmbH, 6100 Darmstadt	Bindemittel fuer arzneimittelueberzuege.
JPS5362270U (fr) *	1976-10-27	1978-05-26
DE3039073A1 (de) *	1980-10-16	1982-05-19	Röhm GmbH, 6100 Darmstadt	Umhuelltes acetylsalicylsaeurepraeparat

1982
- 1982-03-11 DE DE3208791A patent/DE3208791A1/de not_active Withdrawn
1983
- 1983-03-03 EP EP83102056A patent/EP0088951B1/fr not_active Expired
- 1983-03-03 FI FI830718A patent/FI77780C/fi not_active IP Right Cessation
- 1983-03-03 DE DE8383102056T patent/DE3372173D1/de not_active Expired
- 1983-03-03 AT AT83102056T patent/ATE27908T1/de not_active IP Right Cessation
- 1983-03-07 DD DD83248556A patent/DD207150A5/de not_active IP Right Cessation
- 1983-03-07 JP JP58036080A patent/JPS58167521A/ja active Granted
- 1983-03-10 HU HU83831A patent/HU187058B/hu unknown
- 1983-03-11 US US06/474,469 patent/US4520172A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP0088951B1 (fr)	1987-06-24
EP0088951A3 (en)	1985-05-15
JPH0534335B2 (fr)	1993-05-21
JPS58167521A (ja)	1983-10-03
DE3208791A1 (de)	1983-09-22
EP0088951A2 (fr)	1983-09-21
DE3372173D1 (en)	1987-07-30
FI77780C (fi)	1989-05-10
ATE27908T1 (de)	1987-07-15
FI830718L (fi)	1983-09-12
FI77780B (fi)	1989-01-31
US4520172A (en)	1985-05-28
FI830718A0 (fi)	1983-03-03
HU187058B (en)	1985-11-28

Legal Events

Date	Code	Title	Description
1996-03-14	ENJ	Ceased due to non-payment of renewal fee

Publication	Publication Date	Title
EP0088951B1 (fr)	1987-06-24	Procédé pour l'enrobage de formes galéniques à l'aide d'une composition d'enrobage dispersée dans l'eau
EP0181515B1 (fr)	1990-09-05	Procédé pour la préparation d'une dispersion aqueuse d'un produit d'enrobage et son utilisation pour enrober des compositions pharmaceutiques
DE3049179C2 (fr)	1987-07-02
EP0058765B1 (fr)	1985-02-20	Enrobage soluble ou gonflable dans le suc gastrique, son utilisation dans un procédé d'enrobage de formes pharmaceutiques
EP0704208B1 (fr)	2004-03-03	Compositions d'enrobage et de liant pour des formes galéniques et des formes galéniques préparées avec ces compositions
EP0164669B1 (fr)	1991-01-23	Procédé pour enrober des formes pharmaceutiques
EP0545209B1 (fr)	1996-07-03	Poudres de dispersion redispersable d'un copolymère de N-vinylpyrrolidone et d'acétate de vinyle, leur préparation et usage
EP0575930B1 (fr)	1997-03-12	Procédé pour la préparation de formes pharmaceutiques retard solides
DE2031871A1 (de)	1971-12-30	Überzugsmasse für Arzneiformen
DD232646A5 (de)	1986-02-05	Waessrige dispersion eines ueberzugmittels fuer arzneiformen
EP1572162A1 (fr)	2005-09-14	Procede de fabrication de formes galeniques et de complements alimentaires pellicules a gradients de concentration dans la pellicule
EP0485840B2 (fr)	1999-03-03	Composition pharmaceutique orale et agent d'enrobage, contenant un polysaccharide dégradable dans le colon
WO2002026845A1 (fr)	2002-04-04	Dispersion polymere aqueuse
EP0536595B1 (fr)	1995-07-05	Procédé pour enrober des formes pharmaceutiques
EP0403959B1 (fr)	1993-08-25	Composition d'enduction aqueuse filmogène pour médicaments solides, procédé de sa préparation et son utilisation
DE69904280T2 (de)	2003-10-02	Wässriges Beschichtungsmaterial und Verfahren zur Herstellung von festen Arzneimittelformen
DD233940A5 (de)	1986-03-19	Verfahren zum ueberziehen von arzneiformen
EP1151015B1 (fr)	2002-05-29	Procede pour reduire les odeurs degagees par des dispersions aqueuses de copolymeres constitues d'un aromatique vinylique et de 1,3-diene, stabilises par des colloides protecteurs
DE3426587A1 (de)	1986-01-30	Verfahren zum ueberziehen von arzneiformen
DE10048888A1 (de)	2002-04-11	Wässrige Polymerdispersion
DE1617351C (de)	1972-08-03	Überzugsmittel fur Arzneitabletten
EP0624169A1 (fr)	1994-11-17	Utilisation de copolymerisats greffes en emulsion comme agents filmogenes dans des fixants pour les cheveux, et procede de fabrication de ces copolymerisats
DE906967C (de)	1954-03-18	Verfahren zur Herstellung von homogenen UEberzugsmischungen